Welcome To  NEM   

Journals(Abstract)

纤维蛋白原与白蛋白比值和全身炎症免疫指数在结直肠癌 患者中的应用价值

王雨欣 胡 滢

 赣南医科大学第一附属医院

摘要(Abstract):

结直肠癌(Colorectal Cancer, CRC)的发病率与死亡率逐年上升,已成为全球最常见的癌症之一。炎症反应在结直肠癌 的发生、发展和转移中起着重要作用。纤维蛋白原与白蛋白比值(FAR)和全身炎症免疫指数(SII)作为炎症相关生物标志物,近 年来被提出作为结直肠癌诊断和预后评估的潜在指标。本综述旨在探讨这两种炎症标志物在结直肠癌中的应用价值,特别是在早期 诊断、临床预后评估及治疗反应监测中的潜力。


关键词(KeyWords):

结直肠癌;纤维蛋白原与白蛋白比值;全身炎症反应指数;炎症指标


参考文献(References):

[1] Lei Z ,Qing-Gen C ,Shu-Qi L , et al.Preoperative fibrinogen to prealbumin ratio as a novel predictor for clinical outcome of hepatocellular carcinoma[. J]. Future oncology(London,England), 2018, 15(1):13-22. 

[2]Zhao S ,Ju Y, Gao B , et al.The value of FPR, FAR, CAR,CPR in the auxiliary diagnosis of colon cancer.[J]. Medicine, 2024, 103(31):e39133. 

[3] Circulating fibrinogen to pre‐albumin ratio is a promising biomarker for diagnosis of colorectal cancer[J]. Journal of clinical laboratory analysis, 2019, 33(1):e22635.

[4]汪晓东,欧阳书睿,吕东昊,等.纤维蛋白原联合多层 螺旋 CT 术前预测结直肠癌淋巴结转移[J].中国普外基础与临床 杂志,2009,16(09):757-762. 

[5]Wen X ,Sun H ,Du S ,et al.A nomogram of inflammatory indexes for preoperatively predicting the risk of lymph node metastasis in colorectal cancer.[J].Techniques in coloproctology,2024, 28 (1):148. 

[6] Liqun Z ,Jingdong Z ,Yuanhe W , et al.Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer.[J]. Journal of clinical laboratory analysis,2019,33(8):e22958. [7]WANG Y Y,LIU Z Z,XU D,et al. Fibrinogen–Albumin Ratio Index ( FARI ) : A More Promising Inflammation-Based Prognostic Marker for Patients Undergoing Hepatectomy for Colorectal Liver Metastases[J]. Annals of Surgical Oncology,2019,26(11): 3682-3692. 

[8] ZHAO X , ZHOU Y, LIU B, et al. Preoperative Neutrophil-Lymphocyte Ratio(NLR)-Binding Fibrinogen-Albumin Ratio (FAR) Is Superior to Platelet-Lymphocyte Ratio (PLR) -Binding Fibrinogen-Albumin Ratio ( FAR ) and Lymphocyte-Monocyte (LMR)-Binding Fibrinogen-Albumin Ratio (FAR) as Predictors of Survival in Surgical Patients with Colorectal Adenocarcinoma[J]. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research , 2023 , 29: ce939442-1-ce939442-10. 

[9]Yan H ,Liu T ,Yu R ,et al. The role of preoperative FPR and FAR in prognostic evaluation of stages II and III radical colorectal cancer: A single-center retrospective study[. J]. Medicine,2024,103 (20):e38145-e38145. 

[10]Zhewen F ,Huajun L ,Xiaobao Y ,et al. Diagnostic Value of Inflammation-Related Indicators in Distinguishing Early Colon Cancer and Adenomatous Polyps.[J]. Cancer control : journal of the Moffitt Cancer Center , 2023 , 3010732748231180745-10732748231180745. 

[11] Hasirci I , Ahin A .Importance of the neutrophil – lymphocyte ratio and systemic immune-inflammation index in predicting colorectal pathologies in fecal occult blood-positive patients[J].JOURNAL of CLINICAL LABORATORY ANALYSIS, 2023, 37(7):6. 

[12]Alessandro P ,Emanuela S ,Luigi C ,et al.Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer.[J]. Oncotarget,2016,7 (22):33210-9. 

[13]Meilian D ,Yonggang S ,Jing Y , et al.Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis[J]. Therapeutic Advances in Medical Oncology , 2020 , 121758835920937425-1758835920937425. 

[14] Tan Y ,Hu B ,Li Q , et al.Prognostic value and clinicopathological significance of pre-and post-treatment systemic immune-inflammation index in colorectal cancer patients: a meta-analysis[J]. World Journal of Surgical Oncology, 2025, 23 (1):11-11.

技术支持:人人站CMS
Powered by RRZCMS